Precision BioSciences, Inc. (DTIL) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
302 EAST PETTIGREW STREET DURHAM, NC 27701 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 189,576 | 143,663 | 89,798 | 180,886 | |||
| Cash and cash equivalents | 189,576 | 143,663 | 89,798 | 180,886 | |||
| Receivables | 720 | 488 | 10,000 | 965 | |||
| Prepaid expense | 7,552 | 17,434 | 5,762 | 9,497 | |||
| Other current assets | 1,257 | 169 | 4 | 2,324 | |||
| Total current assets: | 199,105 | 161,754 | 105,564 | 193,672 | |||
| Noncurrent Assets | |||||||
| Operating lease, right-of-use asset | 2,974 | 4,180 | 6,410 | ||||
| Property, plant and equipment | 20,190 | 25,154 | 35,090 | 39,571 | |||
| Long-term investments and receivables | 4,748 | 6,842 | |||||
| Long-term investments | 4,748 | 6,842 | |||||
| Intangible assets, net (including goodwill) | 1,348 | 2,048 | 1,373 | 1,432 | |||
| Intangible assets, net (excluding goodwill) | 1,348 | 2,048 | 1,373 | 1,432 | |||
| Deferred income tax assets | 1,168 | 1,548 | |||||
| Other noncurrent assets | 2,570 | 4,641 | 1,721 | 558 | |||
| Other undisclosed noncurrent assets | 6,066 | 5,331 | |||||
| Total noncurrent assets: | 39,064 | 49,744 | 44,594 | 41,561 | |||
| TOTAL ASSETS: | 238,169 | 211,498 | 150,158 | 235,233 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 7,484 | 7,909 | 6,537 | 6,462 | |||
| Employee-related liabilities | ✕ | ✕ | 6,765 | 5,745 | 4,425 | ||
| Accounts payable | 1,225 | 1,144 | 792 | 2,037 | |||
| Accrued liabilities | 6,259 | ||||||
| Deferred revenue | 46,192 | 21,244 | 30,236 | 16,486 | |||
| Debt | |||||||
| Disposal group, including discontinued operation | |||||||
| Other liabilities | 745 | 977 | 854 | ||||
| Other undisclosed current liabilities | 5,243 | 5,850 | 5,202 | 3,984 | |||
| Total current liabilities: | 59,664 | 35,980 | 42,829 | 26,932 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation: | 4,813 | 8,586 | |||||
| Liabilities, other than long-term debt | 87,017 | 68,607 | 54,318 | 69,987 | |||
| Deferred revenue | 82,872 | 67,015 | 53,926 | 65,895 | |||
| Deferred rent credit | 4,092 | ||||||
| Deferred income tax liabilities | 1,168 | 1,548 | |||||
| Other liabilities | 201 | 44 | 392 | ||||
| Operating lease, liability | 2,776 | 4,813 | 8,586 | ||||
| Other undisclosed noncurrent liabilities | 31,055 | 10,930 | |||||
| Total noncurrent liabilities: | 118,072 | 84,350 | 62,904 | 69,987 | |||
| Total liabilities: | 177,736 | 120,330 | 105,733 | 96,919 | |||
| Equity | |||||||
| Equity, attributable to parent, including: | 60,433 | 91,168 | 44,425 | 138,314 | |||
| Common stock | |||||||
| Treasury stock, value | (952) | (952) | (952) | (952) | |||
| Additional paid in capital | 489,696 | 408,795 | 331,450 | 316,333 | |||
| Accumulated deficit | (428,312) | (316,675) | (286,073) | (177,067) | |||
| Other undisclosed equity, attributable to parent | 1 | ||||||
| Total equity: | 60,433 | 91,168 | 44,425 | 138,314 | |||
| TOTAL LIABILITIES AND EQUITY: | 238,169 | 211,498 | 150,158 | 235,233 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|
| Revenues | 25,098 | 115,529 | 24,285 | 1,070,000 | ||
| Gross profit: | 25,098 | 115,529 | 24,285 | 1,070,000 | ||
| Operating expenses | (125,464) | (154,931) | (134,113) | (109,442) | ||
| Other undisclosed operating loss | (1,047,762) | |||||
| Operating loss: | (100,366) | (39,402) | (109,828) | (87,204) | ||
| Nonoperating income (expense) | (11,271) | 14,993 | 1,644 | (5,673) | ||
| Investment income, nonoperating | 6,193 | 822 | ||||
| Other nonoperating income (expense) | (11,271) | 8,800 | 822 | (5,673) | ||
| Interest and debt expense | (1,111) | (132) | (182) | |||
| Loss from continuing operations before equity method investments, income taxes: | (112,748) | (24,541) | (108,184) | (93,059) | ||
| Income from equity method investments | 184 | |||||
| Loss from continuing operations before income taxes: | (112,748) | (24,357) | (108,184) | (93,059) | ||
| Income tax expense | (23) | |||||
| Loss from continuing operations: | (112,748) | (24,357) | (108,207) | (93,059) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (24,357) | (108,207) | (93,059) | |
| Other undisclosed net income (loss) | 1,111 | (6,245) | (799) | 182 | ||
| Net loss: | (111,637) | (30,602) | (109,006) | (92,877) | ||
| Other undisclosed net income attributable to parent | ||||||
| Net loss available to common stockholders, diluted: | (111,637) | (30,602) | (109,006) | (92,877) | ||
Comprehensive Income ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|
| Net loss: | (111,637) | (30,602) | (109,006) | (92,877) | ||
| Comprehensive loss, net of tax, attributable to parent: | (111,637) | (30,602) | (109,006) | (92,877) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.